Alkermes, Inc.
Alkermes, Inc., a prominent biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for central nervous system (CNS) disorders and addiction. Founded in 1987, Alkermes has established itself as a leader in the industry, with significant operational presence across North America and Europe. The company is renowned for its unique drug delivery technologies and a robust portfolio of products, including treatments for schizophrenia, depression, and opioid dependence. Alkermes' commitment to addressing complex medical needs has positioned it favourably in the market, with notable achievements in advancing patient care through its proprietary formulations. With a strong emphasis on research and development, Alkermes continues to drive innovation in the biopharmaceutical landscape.
DitchCarbon Score
How does Alkermes, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alkermes, Inc.'s score of 13 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Alkermes, Inc.'s reported carbon emissions
Alkermes, Inc., headquartered in the US, has reported its carbon emissions data for the years 2015 to 2017. In 2015, the company emitted approximately 412,205,000 kg CO2e from Scope 1 sources and about 112,198,000 kg CO2e from Scope 2 sources. Additionally, Scope 3 emissions included approximately 140,000 kg CO2e from capital goods, 65,000 kg CO2e from purchased goods and services, 25,000 kg CO2e from waste generated in operations, and 60,000 kg CO2e from fuel and energy-related activities. In 2016, Alkermes reported a reduction in Scope 1 emissions to about 345,064,000 kg CO2e and Scope 2 emissions to approximately 104,210,000 kg CO2e. Scope 3 emissions also saw slight variations, with capital goods emissions at 125,000 kg CO2e, purchased goods and services at 58,000 kg CO2e, waste generated in operations at 30,000 kg CO2e, and fuel and energy-related activities at 52,000 kg CO2e. By 2017, the company continued to reduce its emissions, with Scope 1 emissions at approximately 337,524,000 kg CO2e and Scope 2 emissions at about 110,525,000 kg CO2e. Scope 3 emissions included 177,000 kg CO2e from capital goods, 60,000 kg CO2e from purchased goods and services, 20,000 kg CO2e from waste generated in operations, and 28,000 kg CO2e from fuel and energy-related activities. Despite these reductions, Alkermes has not publicly committed to specific reduction targets or initiatives, nor have they joined any climate pledges. The company’s emissions data reflects a commitment to monitoring and potentially reducing its carbon footprint, aligning with industry standards for climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2015 | 2016 | 2017 | |
|---|---|---|---|
| Scope 1 | 412,205,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 112,198,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 290,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alkermes, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
